Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

New COX-2-selective compounds in development at Merck Frosst

April 9, 1998

Aspartame has potent antiarthritic activity in preclinical models and arthritic subjects

April 8, 1998

Celtrix reports interim results of phase II clinical study of SomatoKine

April 8, 1998

HMR files for European, American approval of arthritis drug

April 7, 1998

Inhibitors of MMP enzymes synthesized at American Cyanamid

April 7, 1998

Immunex and ArQule form alliance to discover new antiinflammatory drug candidates

April 3, 1998

MGI now distributing Salagen for Sjogren's syndrome in U.S.

April 2, 1998

Celecoxib copromotion agreement expanded

March 26, 1998

First report of nonpeptide compounds as MHC class II inhibitors

March 26, 1998

Further mechanism-of-action studies conducted on T-614

March 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...